Evidence map›Paper›PMID 32915503›Full record

ReviewMolecular oncology2021

Advances in optical gastrointestinal endoscopy: a technical review.

Yubo Tang, Sharmila Anandasabapathy, Rebecca Richards-Kortum

Abstract readReview
In one paragraph

Review in Molecular oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. AI-Enhanced Vibrational Capsule for Minimally Invasive Detection of Abnormal Bowel Tissue.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Review
  7. Review
  8. A Bionic Multichannel Whisker System for Assisting Endoluminal Intervention.Cyborg and bionic systems (Washington, D.C.) · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Artificial Intelligence in Upper Gastrointestinal Diagnosis.The Korean journal of helicobacter and upper gastrointestinal research · 2025
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yubo TangDepartment of Bioengineering, Rice University, Houston, TX, USA.ORCID 0000-0003-2568-8940
Sharmila AnandasabapathyDivision of Gastroenterology, Baylor College of Medicine, Houston, TX, USA.
Rebecca Richards-KortumDepartment of Bioengineering, Rice University, Houston, TX, USA.

Funding

A Low-Cost Tethered Capsule Endoscope for Esophageal Cancer ScreeningR21EB023431 · NIBIB · RICE UNIVERSITY · PI RICHARDS-KORTUM, REBECCA R. · 2017 to 2018
$434k
NIBIB NIH HHS R21 EB023431
6 · The paper itself

Abstract

Optical endoscopy is the primary diagnostic and therapeutic tool for management of gastrointestinal (GI) malignancies. Most GI neoplasms arise from precancerous lesions; thus, technical innovations to improve detection and diagnosis of precancerous lesions and early cancers play a pivotal role in improving outcomes. Over the last few decades, the field of GI endoscopy has witnessed enormous and focused efforts to develop and translate accurate, user-friendly, and minimally invasive optical imaging modalities. From a technical point of view, a wide range of novel optical techniques is now available to probe different aspects of light-tissue interaction at macroscopic and microscopic scales, complementing white light endoscopy. Most of these new modalities have been successfully validated and translated to routine clinical practice. Herein, we provide a technical review of the current status of existing and promising new optical endoscopic imaging technologies for GI cancer screening and surveillance. We summarize the underlying principles of light-tissue interaction, the imaging performance at different scales, and highlight what is known about clinical applicability and effectiveness. Furthermore, we discuss recent discovery and translation of novel molecular probes that have shown promise to augment endoscopists' ability to diagnose GI lesions with high specificity. We also review and discuss the role and potential clinical integration of artificial intelligence-based algorithms to provide decision support in real time. Finally, we provide perspectives on future technology development and its potential to transform endoscopic GI cancer detection and diagnosis.

Indexed as

Gastrointestinal NeoplasmsPrecancerous ConditionsArtificial IntelligenceEndoscopy, GastrointestinalHumansOptical Imaginggastrointestinal tractmachine learningmolecular probeoptical endoscopy

Identifiers

PMID32915503
PMCPMC8486567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.